Autoimmune pancreatitis

Expert Review of Clinical Immunology

Volumn 5, Issue 6, 2009, Pages 801-811

  Barth, Erin ^a   Savides, Thomas J ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimmune; Autoimmune cholangitis; IgG4; Immunoglobulin subtype 4; Lymphoplasmacytic sclerosing; Pancreatitis

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G4; STEROID;

AUTOIMMUNE PANCREATITIS; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DRUG DOSE REDUCTION; DRUG RESPONSE; HISTOPATHOLOGY; HUMAN; LYMPHOCYTIC INFILTRATION; PREVALENCE; RECOMMENDED DRUG DOSE; REVIEW; SYMPTOM;

EID: 77949859761     PISSN: 1744666X     EISSN: None     Source Type: Journal    
DOI: 10.1586/eci.09.54     Document Type: Review

References (77)

1. Abraham SC, Wilentz RE, Yeo CJ et al. Pancreaticoduodenectomy (Whipple resections) in patients without malignancy: are they all chronic pancreatitis? Am. J. Surg. Pathol. 27(1), 110-120 (2003).
2. Moon SH, Kim MH, Park DH et al. Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study. Gut 57(12), 1704-1712 (2008).
3. Weber SM, Cubukcu-Dimopulo O, Palesty JA et al. Lymphoplasmacytic sclerosing pancreatitis: inflammatory mimic of pancreatic carcinoma. J. Gastrointest. Surg. 7(1), 129-137 (2003).
4. Sarles H, Sarles JC, Muratore R, Guien C. Chronic inflammatory sclerosis of the pancreas - an autonomous pancreatic disease? Am. J. Dig. Dis. 6, 688-698 (1961).
5. Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig. Dis. Sci. 40(7), 1561-1568 (1995).
6. Ectors N, Maillet B, Aerts R et al. Non-alcoholic duct destructive chronic pancreatitis. Gut 41(2), 263-268 (1997).
7. Hamano H, Kawa S, Horiuchi A et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N. Engl. J. Med. 344(10), 732-738 (2001).
8. Wakabayashi T, Kawaura Y, Satomura Y et al. Clinical study of chronic pancreatitis with focal irregular narrowing of the main pancreatic duct and mass formation: comparison with chronic pancreatitis showing diffuse irregular narrowing of the main pancreatic duct. Pancreas 25(3), 283-289 (2002).
9. Members of the Criteria Committee for Autoimmune Pancreatitis of the Japan Pancreas Society. Diagnostic criteria for autoimmune pancreatitis by the Japan Pancreas Society. J. Jpn Pan. Soc. 17, 585-587 (2002).
10. Okazaki K, Kawa S, Kamisawa T et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J. Gastroenterol. 41(7), 626-631 (2006).
11. Kim KP, Kim MH, Kim JC, Lee SS, Seo DW, Lee SK. Diagnostic criteria for autoimmune chronic pancreatitis revisited. World J. Gastroenterol. 12(16), 2487-2496 (2006).
12. Chari ST, Smyrk TC, Levy MJ et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin. Gastroenterol. Hepatol. 4(8), 1010-1016 (2006).
13. Otsuki M, Chung JB, Okazaki K et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J. Gastroenterol. 43(6), 403-408 (2008).
14. Frulloni L, Bovo P, Brunelli S et al. Elevated serum levels of antibodies to carbonic anhydrase I and II in patients with chronic pancreatitis. Pancreas 20(4), 382-388 (2000).
15. Kim KP, Kim MH, Song MH, Lee SS, Seo DW, Lee SK. Autoimmune chronic pancreatitis. Am. J. Gastroenterol. 99(8), 1605-1616 (2004).
16. Pearson RK, Longnecker DS, Chari ST et al. Controversies in clinical pancreatology: autoimmune pancreatitis: does it exist? Pancreas 27(1), 1-13 (2003).
17. Kamisawa T, Funata N, Hayashi Y et al. A new clinicopathological entity of IgG4-related autoimmune disease. J. Gastroenterol. 38(10), 982-984 (2003).
18. Choi EK, Kim MH, Kim JC et al. The Japanese diagnostic criteria for autoimmune chronic pancreatitis: is it completely satisfactory? Pancreas 33(1), 13-19 (2006).
19. Hirano K, Kawabe T, Yamamoto N et al. Serum IgG4 concentrations in pancreatic and biliary diseases. Clin. Chim. Acta 367(1-2), 181-184 (2006).
20. Horiuchi A, Kawa S, Akamatsu T et al. Characteristic pancreatic duct appearance in autoimmune chronic pancreatitis: a case report and review of the Japanese literature. Am. J. Gastroenterol. 93(2), 260-263 (1998).
21. Zamboni G, Luttges J, Capelli P et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch. 445(6), 552-563 (2004).
22. Okazaki K, Uchida K, Chiba T. Recent concept of autoimmune-related pancreatitis. J. Gastroenterol. 36(5), 293-302 (2001).
23. Ghazale A, Chari ST, Smyrk TC et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am. J. Gastroenterol. 102(8), 1646-1653 (2007).
24. Farrell JJ, Garber J, Sahani D, Brugge WR. EUS findings in patients with autoimmune pancreatitis. Gastrointest. Endosc. 60(6), 927-936 (2004).
25. Aoki S, Nakazawa T, Ohara H et al. Immunohistochemical study of autoimmune pancreatitis using anti-IgG4 antibody and patients sera. Histopathology 47(2), 147-158 (2005).
26. Kamisawa T, Egawa N, Nakajima H. Autoimmune pancreatitis is a systemic autoimmune disease. Am. J. Gastroenterol. 98(12), 2811-2812 (2003).
27. Okazaki K, Uchida K, Ohana M et al. Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/ Th2-type cellular immune response. Gastroenterology 118(3), 573-581 (2000).
28. Aparisi L, Farre A, Gomez-Cambronero L et al. Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis. Gut 54(5), 703-709 (2005).
29. Taniguchi T, Okazaki K, Okamoto M et al. High prevalence of autoantibodies against carbonic anhydrase II and lactoferrin in Type 1 diabetes: concept of autoimmune exocrinopathy and endocrinopathy of the pancreas. Pancreas 27(1), 26-30 (2003).
30. Kino-Ohsaki J, Nishimori I, Morita M et al. Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis and Sjogrens syndrome. Gastroenterology 110(5), 1579-1586 (1996).
31. Gordon SC, Quattrociocchi-Longe TM, Khan BA et al. Antibodies to carbonic anhydrase in patients with immune cholangiopathies. Gastroenterology 108(6), 1802-1809 (1995).
32. Itoh Y, Reichlin M. Antibodies to carbonic anhydrase in systemic lupus erythematosus and other rheumatic diseases. Arthritis Rheum. 35(1), 73-82 (1992).
33. Invernizzi P, Battezzati PM, Crosignani A et al. Antibody to carbonic anhydrase II is present in primary biliary cirrhosis (PBC) irrespective of antimitochondrial antibody status. Clin. Exp. Immunol. 114(3), 448-454 (1998).
34. Hosoda H, Okawa-Takatsuji M, Shinmura W, Hasimoto N, Ozaki Y, Ikeda Y. Potential for differential diagnosis of autoimmune pancreatitis and pancreatic cancer using carbonic anhydrase II antibody. Pancreas 37(1), e1-e7 (2008).
35. Chen RY, Adams DB. IgG4 levels in non-Japanese patients with autoimmune sclerosing pancreatitis. N. Engl. J. Med. 346(24), 1919 (2002).
36. Aalberse RC, Van Milligen F, Tan KY, Stapel SO. Allergen-specific IgG4 in atopic disease. Allergy 48(8), 559-569 (1993).
37. Parlowsky T, Welzel J, Amagai M, Zillikens D, Wygold T. Neonatal pemphigus vulgaris: IgG4 autoantibodies to desmoglein 3 induce skin blisters in newborns. J. Am. Acad. Dermatol. 48(4), 623-625 (2003).
38. Warren SJ, Arteaga LA, Rivitti EA et al. The role of subclass switching in the pathogenesis of endemic pemphigus foliaceus. J. Invest. Dermatol. 120(1), 104-108 (2003).
39. Hussain R, Poindexter RW, Ottesen EA. Control of allergic reactivity in human filariasis. Predominant localization of blocking antibody to the IgG4 subclass. J. Immunol. 148(9), 2731-2737 (1992).
40. Aceti A, Pennica A, Teggi A et al. IgG subclasses in human hydatid disease: prominence of the IgG4 response. Int. Arch. Allergy Immunol. 102(4), 347-351 (1993).
41. Morselli-Labate AM, Pezzilli R. Usefulness of serum IgG4 in the diagnosis and follow up of autoimmune pancreatitis: a systematic literature review and metaanalysis. J. Gastroenterol. Hepatol. 24(1), 15-36 (2009).
42. Okazaki K, Uchida K, Fukui T. Recent advances in autoimmune pancreatitis: concept, diagnosis, and pathogenesis. J. Gastroenterol. 43(6), 409-418 (2008).
43. Notohara K, Burgart LJ, Yadav D, Chari S, Smyrk TC. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am. J. Surg. Pathol. 27(8), 1119-1127 (2003).
44. Kloppel G, Sipos B, Zamboni G, Kojima M, Morohoshi T. Autoimmune pancreatitis: histo- and immunopathological features. J. Gastroenterol. 42(Suppl. 18), 28-31 (2007).
45. Esposito I, Bergmann F, Penzel R et al. Oligoclonal T-cell populations in an inflammatory pseudotumor of the pancreas possibly related to autoimmune pancreatitis: an immunohistochemical and molecular analysis. Virchows Arch. 444(2), 119-126 (2004).
46. Zhang L, Notohara K, Levy MJ, Chari ST, Smyrk TC. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod. Pathol. 20(1), 23-28 (2007).
47. Finkelberg DL, Sahani D, Deshpande V, Brugge WR. Autoimmune pancreatitis. N. Engl. J. Med. 355(25), 2670-2676 (2006).
48. Kamisawa T, Funata N, Hayashi Y et al. Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut 52(5), 683-687 (2003).
49. Ohara H, Nakazawa T, Ando T, Joh T. Systemic extrapancreatic lesions associated with autoimmune pancreatitis. J. Gastroenterol. 42(Suppl. 18), 15-21 (2007).
50. Kamisawa T, Egawa N, Nakajima H, Tsuruta K, Okamoto A. Extrapancreatic lesions in autoimmune pancreatitis. J. Clin. Gastroenterol. 39(10), 904-907 (2005).
51. Kamisawa T, Egawa N, Inokuma S et al. Pancreatic endocrine and exocrine function and salivary gland function in autoimmune pancreatitis before and after steroid therapy. Pancreas 27(3), 235-238 (2003).
52. Kulling D, Tresch S, Renner E. Triad of sclerosing cholangitis, chronic pancreatitis, and Sjögrens syndrome: case report and review. Gastrointest. Endosc. 57(1), 118-120 (2003).
53. Niemela S, Lehtola J, Karttunen T, Lahde S. Pancreatitis in patients with chronic inflammatory bowel disease. Hepatogastroenterology 36(3), 175-177 (1989).
54. Kobayashi S, Yoshida M, Kitahara T, Abe Y, Tsuchida A, Nojima Y. Autoimmune pancreatitis as the initial presentation of systemic lupus erythematosus. Lupus 16(2), 133-136 (2007).
55. Montefusco PP, Geiss AC, Bronzo RL, Randall S, Kahn E, McKinley MJ. Sclerosing cholangitis, chronic pancreatitis, and Sjögrens syndrome: a syndrome complex. Am. J. Surg. 147(6), 822-826 (1984).
56. Epstein O, Chapman RW, Lake-Bakaar G, Foo AY, Rosalki SB, Sherlock S. The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis. Gastroenterology 83(6), 1177-1182 (1982).
57. Kamisawa T, Matsukawa M, Ohkawa M. Autoimmune pancreatitis associated with retroperitoneal fibrosis. JOP 6(3), 260-263 (2005).
58. Kamisawa T, Tu Y, Egawa N, Sakaki N, Inokuma S, Kamata N. Salivary gland involvement in chronic pancreatitis of various etiologies. Am. J. Gastroenterol. 98(2), 323-326 (2003).
59. Takato H, Yasui M, Ichikawa Y et al. Nonspecific interstitial pneumonia with abundant IgG4-positive cells infiltration, which was thought as pulmonary involvement of IgG4-related autoimmune disease. Intern. Med. 47(4), 291-294 (2008).
60. Takeda S, Haratake J, Kasai T, Takaeda C, Takazakura E. IgG4-associated idiopathic tubulointerstitial nephritis complicating autoimmune pancreatitis. Nephrol. Dial. Transplant. 19(2), 474-476 (2004).
61. Yang DH, Kim KW, Kim TK et al. Autoimmune pancreatitis: radiologic findings in 20 patients. Abdom. Imaging 31(1), 94-102 (2006).
62. Procacci C, Carbognin G, Biasiutti C et al. Autoimmune pancreatitis: possibilities of CT characterization. Pancreatology 1(3), 246-253 (2001).
63. Sahani DV, Kalva SP, Farrell J et al. Autoimmune pancreatitis: imaging features. Radiology 233(2), 345-352 (2004).
64. Sahani DV, Sainani NI, Deshpande V, Shaikh MS, Frinkelberg DL, Fernandez-del CC. Autoimmune pancreatitis: disease evolution, staging, response assessment, and CT features that predict response to corticosteroid therapy. Radiology 250(1), 118-129 (2009).
65. Eloubeidi MA, Chen VK, Eltoum IA et al. Endoscopic ultrasound-guided fine needle aspiration biopsy of patients with suspected pancreatic cancer: diagnostic accuracy and acute and 30-day complications. Am. J. Gastroenterol. 98(12), 2663-2668 (2003).
66. Eloubeidi MA, Varadarajulu S, Desai S et al. A prospective evaluation of an algorithm incorporating routine preoperative endoscopic ultrasound-guided fine needle aspiration in suspected pancreatic cancer. J. Gastrointest. Surg. 11(7), 813-819 (2007).
67. Levy MJ, Jondal ML, Clain J, Wiersema MJ. Preliminary experience with an EUS-guided trucut biopsy needle compared with EUS-guided FNA. Gastrointest. Endosc. 57(1), 101-106 (2003).
68. Levy MJ, Reddy RP, Wiersema MJ et al. EUS-guided trucut biopsy in establishing autoimmune pancreatitis as the cause of obstructive jaundice. Gastrointest. Endosc. 61(3), 467-472 (2005).
69. Mizuno N, Bhatia V, Hosoda W et al. Histological diagnosis of autoimmune pancreatitis using EUS-guided trucut biopsy: a comparison study with EUSFNA. J. Gastroenterol. 44(7), 742-750 (2009).
70. Ito T, Nishimori I, Inoue N et al. Treatment for autoimmune pancreatitis: consensus on the treatment for patients with autoimmune pancreatitis in Japan. J. Gastroenterol. 42(Suppl. 18), 50-58 (2007).
71. Kamisawa T, Shimosegawa T, Okazaki K et al. Standard steroid therapy for autoimmune pancreatitis. Gut (2009) (Epub ahead of print).
72. Saito T, Tanaka S, Yoshida H et al. A case of autoimmune pancreatitis responding to steroid therapy. Evidence of histologic recovery. Pancreatology 2(6), 550-556 (2002).
73. Kojima E, Kimura K, Noda Y, Kobayashi G, Itoh K, Fujita N. Autoimmune pancreatitis and multiple bile duct strictures treated effectively with steroid. J. Gastroenterol. 38(6), 603-607 (2003).
74. Kubota K, Iida H, Fujisawa T et al. Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis. Gastrointest. Endosc. 66(6), 1142-1151 (2007).
75. Park DH, Kim MH, Oh HB et al. Substitution of aspartic acid at position 57 of the DQb1 affects relapse of autoimmune pancreatitis. Gastroenterology 134(2), 440-446 (2008).
76. Church NI, Pereira SP, Deheragoda MG et al. Autoimmune pancreatitis: clinical and radiological features and objective response to steroid therapy in a UK series. Am. J. Gastroenterol. 102(11), 2417-2425 (2007).
77. Raina A, Yadav D, Krasinskas AM et al. Evaluation and management of autoimmune pancreatitis: experience at a large US center. Am. J. Gastroenterol. 104(9), 2295-2306 (2009).